Polyneuropathy (PN) becomes apparent through pain and missfeelings in hands and feet, e.g. tingling (formication), burning pain and above all numbness. Many patients describe the symptoms as "sock-like"(feet) or "glove-like" (hands). Fine-motor abilities are also often limited, which leads to serious difficulties in writing or buttoning/unbuttoning of garments. There are many causes of polyneuropathy. 200 different causes of polyneuropahty are known, among others, diabetes mellitus and alcohol abuse. But also infectious or metabolic diseases, malnutrition (vitamin deficiency) or medical drugs can cause polyneuropathy.
Polyneuropathy caused by medical drugs is very often related to cancer treatments. It is known as the chemo-induced peripheral neuropathy (CIPN). In particular, substances used to treat breast, ovarian, lung, stomach, brain, throat, prostate and colon cancer can affect the function of the cell membrane of the nerve cell and immune cells. The symptoms are the same as with polyneuropathy having a different cause and they can appear during and well after the end of chemotherapy and thus can last for a very long time.
In order to be able to evaluate the therapy and the course of the treatment for the diagnozed polyneuropathy, especially the chemo-induced peripheral neuropathy, the treating physician uses, among others, standardized questionnaires in the documentation.
MeQoL® ("polyneuropathy") is also based on those questionnaires. With MeQoL® you can document your subjective evaluation of your quality of life and level of stress, as well as the frequency and intensity of pain.
Furthermore, questions are asked about how you perceive the selected symptoms. With regular documentation there is the possibility for you that you document the course of the therapy respectively of the pain and your quality of life during the treatment.
The data is merely saved on your device and will not be forwarded. However, you can discuss the evaluation with your doctor and he will be able to get a better picture of the course of the treatment and, if necessary, alter the therapy. The evaluation can be saved and sent as a screenshot. The upcoming versions of MeQoL® will allow e-mail transmission.
The sooner polyneuropathy is diagnosed and treated, the higher the probability that the disease disappears. You should therefore immediately talk to your doctor if any of these mentioned symptoms appear and document your symptoms and your quality of life with MeQoL®.